James Mann

Full Profile

James has worked with clients operating in the aviation, energy, healthcare, hospitality and technology sectors.

James is admitted as a solicitor in England & Wales

Experience

• Advising Drive System Design, an award-winning and globally trusted engineering consultancy known for developing innovative solutions for electrified propulsion systems, on its sale to Hinduja Tech.
• Advising New Era Music Company, a global record label and media company, on its completed acquisition of Defected Records Ltd and all of its group companies, through a new group holding company, Optimum Defected Holdings Limited.
• Advising a Saudi family office on the restructuring of their corporate and trust structure over multiple jurisdictions including the UK, Switzerland, US, France, BVI and Jersey (consisting of over USD 2 billion of assets).
• Advising a local family business in relation to their significant shareholding (GBP 300 million valuation) in a FTSE 250 company, including advice relating to the Takeover Code, Disclosure and Transparency Rules, Corporate Governance Code, insider dealing and the Market Abuse Regulation.
• Advising a privately-owned biotech company on their refinancing and preparing for a shareholder exit through an acquisition.
• Advising a privately-owned group in the food sector on their restructuring and refinancing (2018 valuation - GBP 1.2 billion).
• Advising directors/shareholders on a strategy to break a deadlocked decentralized derivatives and cryptocurrency platform, including settlement negotiations and buyback agreements.
• Advising an Australian-based design and technology company developing a collapsible container and an IOT container tracking system.
• Advising a Singapore-based renewables developer on the portfolio sale of solar projects in Vietnam.
• Advising finnCap as nominated adviser and broker to SRT Marine Systems plc on a GBP 4.9 million placing with existing and new investors.
• Advising finnCap as Nominated Adviser and Broker to AIM-quoted Parsley Box Group plc on a GBP 6 million placing and open offer.
• Advising SkinBioTherapeutics plc (AIM: SBTX) on a GBP 4 million conditional placing and an associated open offer to raise up to GBP 500,000.
• Advising a biotech company on its initial public offering (IPO) on the London Stock Exchange, which valued the company at GBP 48 million. The standard listing on London’s main market involved a GBP 16.5 million placing.
• Advising a client in relation to the establishment of a new GBP 40 million venture capital fund.
• Advising venture capital firms on early-stage investments in the technology, IT and healthcare sectors, including Hubble, Simply Cook and Patients Know Best.
• Advising a client on the EUR 450 million cross-border acquisition of a German IT systems provider.